In the latest session, Nutex Health Inc (NASDAQ: NUTX) closed at $0.67 down -11.24% from its previous closing price of $0.76. On the day, 759454 shares were traded.
Ratios:
For a deeper understanding of Nutex Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.56. In the meantime, Its Debt-to-Equity ratio is 4.49 whereas as Long-Term Debt/Eq ratio is at 4.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on February 22, 2023, initiated with a Outperform rating and assigned the stock a target price of $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’23 when Vo Thomas T. bought 275,200 shares for $0.23 per share. The transaction valued at 62,195 led to the insider holds 269,822,776 shares of the business.
Vo Thomas T. bought 224,800 shares of NUTX for $51,704 on Nov 17 ’23. The Chief Executive Officer now owns 269,547,576 shares after completing the transaction at $0.23 per share. On Nov 15 ’23, another insider, DeTillio Joshua, who serves as the Chief Operating Officer of the company, bought 140,000 shares for $0.24 each. As a result, the insider paid 34,174 and bolstered with 140,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 0.49.
Stock Price History:
Over the past 52 weeks, NUTX has reached a high of $15.45, while it has fallen to a 52-week low of $0.73.
Shares Statistics:
A total of 45.11M shares are outstanding, with a floating share count of 28.74M.
Earnings Estimates
There are Nkarta, Inc. different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $0.67, with high estimates of $36.92 and low estimates of $6.09.
EPS for the following year is $Stocks, with Stocks analysts recommending between $Mutual Fund and $Stocks.
